ArticleFrontiers in oncology2025

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma.

Benjamin Stubbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.